[go: up one dir, main page]

PT3068404T - Composições para utilização na prevenção ou tratamento de infecções do urt em lactentes ou crianças pequenas em risco - Google Patents

Composições para utilização na prevenção ou tratamento de infecções do urt em lactentes ou crianças pequenas em risco

Info

Publication number
PT3068404T
PT3068404T PT147988547T PT14798854T PT3068404T PT 3068404 T PT3068404 T PT 3068404T PT 147988547 T PT147988547 T PT 147988547T PT 14798854 T PT14798854 T PT 14798854T PT 3068404 T PT3068404 T PT 3068404T
Authority
PT
Portugal
Prior art keywords
infants
prevention
risk
compositions
treatment
Prior art date
Application number
PT147988547T
Other languages
English (en)
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49582658&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT3068404(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of PT3068404T publication Critical patent/PT3068404T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Pediatric Medicine (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dairy Products (AREA)
PT147988547T 2013-11-15 2014-11-14 Composições para utilização na prevenção ou tratamento de infecções do urt em lactentes ou crianças pequenas em risco PT3068404T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13193087 2013-11-15

Publications (1)

Publication Number Publication Date
PT3068404T true PT3068404T (pt) 2021-03-22

Family

ID=49582658

Family Applications (2)

Application Number Title Priority Date Filing Date
PT147988547T PT3068404T (pt) 2013-11-15 2014-11-14 Composições para utilização na prevenção ou tratamento de infecções do urt em lactentes ou crianças pequenas em risco
PT161756523T PT3111942T (pt) 2013-11-15 2014-11-14 Composições para utilização na prevenção ou tratamento de infecções do urt em lactentes ou crianças pequenas em risco

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT161756523T PT3111942T (pt) 2013-11-15 2014-11-14 Composições para utilização na prevenção ou tratamento de infecções do urt em lactentes ou crianças pequenas em risco

Country Status (10)

Country Link
US (2) US10357506B2 (pt)
EP (2) EP3068404B1 (pt)
CN (2) CN105722515A (pt)
AU (1) AU2014350144B2 (pt)
ES (2) ES2857077T3 (pt)
MX (1) MX2016005961A (pt)
PH (1) PH12016500764A1 (pt)
PT (2) PT3068404T (pt)
RU (1) RU2707570C1 (pt)
WO (1) WO2015071389A1 (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10758555B2 (en) * 2013-11-15 2020-09-01 Societe Des Produits Nestle S.A. Compositions for preventing or treating allergies in infants from or fed by non secretor mothers by providing fucosylated-oligosaccharides in particular among infants at risk or born by C-section
AU2014350144B2 (en) * 2013-11-15 2019-11-21 Société des Produits Nestlé S.A. Compositions for use in the prevention or treatment of URT infections in infants or young children at risk
MY182925A (en) 2014-10-31 2021-02-05 Nestle Sa Composition comprising fut2-dependent oligosaccharides and lacto-n-neotetraose for use in promoting brain development and cognition
US10821124B2 (en) * 2015-03-05 2020-11-03 Societe Des Produits Nestle S.A. Compositions for use in improving stool consistency or frequency in infants or young children
WO2016184880A1 (en) 2015-05-19 2016-11-24 Nestec S.A. Kit-of-parts to identify mother's milk missing fucosyltransferase-2 dependent glycans and feeding doses with said glycans
EP3389404B1 (en) 2015-12-15 2019-10-02 Société des Produits Nestlé S.A. Mixture of hmos
EP3493817A1 (en) * 2016-08-04 2019-06-12 Nestec S.A. Nutritional compositions with 2fl and lnnt for use in preventing and/or treating non-rotavirus diarrhea by acting on the gut microbiota dysbiosis
CN110573164B (zh) * 2017-03-08 2023-09-29 N·V·努特里奇亚 用于减轻鼻上皮炎症的含有不可消化的低聚糖的组合物
AU2018272764B2 (en) * 2017-05-24 2024-05-30 Societe Des Produits Nestle S.A. HMOs blends for use in infants or young children for health purposes
US20200281245A1 (en) * 2017-07-07 2020-09-10 Societe Des Products Nestle S.A Human milk fortifier
CN110868872A (zh) * 2017-07-07 2020-03-06 雀巢产品有限公司 人乳强化剂
TW201924696A (zh) 2017-12-01 2019-07-01 瑞士商耐斯泰克公司 母體補充劑
AU2018374516B2 (en) * 2017-12-01 2024-03-07 Societe Des Produits Nestle S.A. Human milk fortifier composition
ES3039685T3 (en) * 2017-12-08 2025-10-23 Chr Hansen Hmo Gmbh Spray-dried tetrasaccharides
EP3494807A1 (en) * 2017-12-11 2019-06-12 Jennewein Biotechnologie GmbH Spray-dried sialyllactose
EP3494804B1 (en) * 2017-12-08 2025-08-13 Chr. Hansen HMO GmbH Spray-dried 3-fucosyllactose
ES3040419T3 (en) * 2017-12-08 2025-10-30 Chr Hansen Hmo Gmbh Spray-dried lacto-n-fucopentaose
WO2019110801A1 (en) * 2017-12-08 2019-06-13 Jennewein Biotechnologie Gmbh Spray-dried 3-fucosyllactose
AU2019409528B2 (en) * 2018-12-20 2025-04-24 Société des Produits Nestlé S.A. Human milk fortifier composition
WO2021195011A1 (en) * 2020-03-24 2021-09-30 Intrinsic Medicine, Inc. Immunomodulatory oligosaccharides for the treatment of viral respiratory infection
AU2021271697A1 (en) * 2020-05-13 2023-02-02 Glycosyn LLC 2'-fucosyllactose for the prevention and treatment of coronavirus-induced inflammation
AU2021273198A1 (en) * 2020-05-13 2023-02-02 Glycosyn LLC Fucosylated oligosaccharides for prevention of coronavirus infection
CN112841316B (zh) * 2021-02-03 2021-11-05 合生元（广州）健康产品有限公司 包含低聚糖的个性化营养组合物
CN116981463A (zh) * 2021-03-22 2023-10-31 雀巢产品有限公司 人乳低聚糖
WO2022221349A2 (en) * 2021-04-15 2022-10-20 Intrinsic Medicine, Inc. Methods and compositions for treating long covid-19
WO2024077253A2 (en) * 2022-10-07 2024-04-11 Coddle Creek Capital, Llc Spiral steroids and precursors thereof for clinical diagnosis and treatment of necrotizing enterocolitis and pre-eclampsia

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0481038B1 (en) 1990-04-16 2002-10-02 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
US5545553A (en) 1994-09-26 1996-08-13 The Rockefeller University Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
US6045854A (en) * 1997-03-31 2000-04-04 Abbott Laboraties Nutritional formulations containing oligosaccharides
US20040058418A1 (en) 2000-04-11 2004-03-25 Tetsuo Endo Alpha 1,2-fucosyltransferase and process for producing fucose-containing complex carbohydrate
EP1689348B1 (en) 2003-12-05 2013-05-15 Children's Hospital Medical Center Oligosaccharide compositions and use thereof in the treatment of infection
US7862808B2 (en) 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
ES2286558T5 (es) 2004-08-24 2013-10-15 N.V. Nutricia Composición nutritiva que comprende transgalactooligosacáridos indigeribles y sacáridos de galactosa digeribles
EP1776877A1 (en) 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
US8361530B2 (en) * 2006-02-10 2013-01-29 Nestec S.A. Oligosaccharide mixture
ES2553636T3 (es) * 2006-03-07 2015-12-10 Nestec S.A. Mezcla simbiótica
WO2008042101A2 (en) 2006-10-02 2008-04-10 Danisco A/S Probiotics for use in reducing the incidence and duration of illness
EP2072052A1 (en) * 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
EP2268793A2 (en) * 2008-02-06 2011-01-05 The Procter & Gamble Company Compositions methods and kits for enhancing immune response to a respiratory condition
RU2495927C2 (ru) * 2008-03-14 2013-10-20 Нестек С.А. Синбиотическая смесь
WO2009151315A1 (en) 2008-06-13 2009-12-17 N.V. Nutricia Nutritional composition for infants delivered via caesarean section
RU2498605C2 (ru) 2008-06-13 2013-11-20 Н.В. Нютрисиа Питательная композиция для грудных детей, рожденных с проведением кесарева сечения
WO2010002241A1 (en) 2008-06-30 2010-01-07 N.V. Nutricia Nutritional composition for infants delivered via caesarean section
JP2010035738A (ja) * 2008-08-04 2010-02-18 Toyota Boshoku Corp 車両用シートの連結装置
ES2989649T3 (es) 2009-07-15 2024-11-27 Nutricia Nv Mezcla de oligosacáridos no digeribles para estimular el sistema inmunitario
EP2813230A1 (en) * 2009-07-15 2014-12-17 N.V. Nutricia Fucosyllactose as breast milk identical non-digestible oligosaccharide for treating and/or preventing infections
FI20096402A0 (fi) 2009-12-28 2009-12-28 Suomen Punainen Risti Veripalv Veriryhmästatuksen käyttö II
US20120315250A1 (en) * 2009-12-28 2012-12-13 Suomen Punainen Risti Veripalvelu Probiotic bifidobacterial composition in accordance with secretor blood group status
CN102946742A (zh) 2010-04-27 2013-02-27 N·V·努特里奇亚 人乳寡糖在婴儿营养物中的用途
US9243753B2 (en) * 2010-08-04 2016-01-26 Scott Fredric Wonders Compressed gas flow initiated and controlled automatic sequencing cascade system for the recharging of compressed gas cylinders
EP2455092A1 (en) 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
EP2465509A1 (en) 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharide composition for treating acute respiratory tract infections
TWI528899B (zh) * 2010-12-29 2016-04-11 杜邦股份有限公司 中離子性殺蟲劑
DK2658549T3 (da) 2010-12-31 2020-06-29 Abbott Lab Fremgangsmåder til reduktion af incidensen af oxidativt stress under anvendelse af humane mælkeoligosaccharider, vitamin c og anti-inflammatoriske midler
MY166946A (en) * 2010-12-31 2018-07-25 Abbott Lab Methods of using human milk oligosaccharides for improving airway respiratory health
AU2014350144B2 (en) * 2013-11-15 2019-11-21 Société des Produits Nestlé S.A. Compositions for use in the prevention or treatment of URT infections in infants or young children at risk

Also Published As

Publication number Publication date
EP3111942A1 (en) 2017-01-04
WO2015071389A1 (en) 2015-05-21
US20160287618A1 (en) 2016-10-06
PH12016500764B1 (en) 2016-05-30
US10357506B2 (en) 2019-07-23
CN105722515A (zh) 2016-06-29
PT3111942T (pt) 2021-03-23
ES2857077T3 (es) 2021-09-28
CN114468302A (zh) 2022-05-13
AU2014350144A1 (en) 2016-04-07
RU2016123516A (ru) 2017-12-20
EP3068404B1 (en) 2021-01-06
RU2707570C1 (ru) 2019-11-28
AU2014350144B2 (en) 2019-11-21
US20190290668A1 (en) 2019-09-26
EP3111942B1 (en) 2021-01-06
US11419885B2 (en) 2022-08-23
PH12016500764A1 (en) 2016-05-30
ES2856013T3 (es) 2021-09-27
EP3068404A1 (en) 2016-09-21
MX2016005961A (es) 2016-12-16

Similar Documents

Publication Publication Date Title
PT3111942T (pt) Composições para utilização na prevenção ou tratamento de infecções do urt em lactentes ou crianças pequenas em risco
ZA201604034B (en) Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children
PT3264923T (pt) Composições para utilização na prevenção ou tratamento de infeções gastrointestinais em lactentes ou crianças pequenas
PH12016500868A1 (en) Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children
IL239355A0 (en) Compositions of gamma-hydroxybutyrate and their use in the treatment of disorders
HUE058903T2 (hu) Kombinációk, amelyek tartalmaznak 5-fenoxi-3H-pirimidin-4-on származékokat és felhasználásuk HIV infekció profilaxisára vagy kezelésére
ZA201506759B (en) Compositions comprising selenium and use of same for the treatment and prevention of disease or conditions associated with mitochondrial dysfunction
IL239736A0 (en) New pitfalls in the treatment of macular degeneration
ZA201703637B (en) Nutritional compositions comprising sn-1 (3) monoacylglycerols for use in the treatment of malabsorption or maldigestion in infants or young children
PT3264922T (pt) Composições para utilização na melhoria da consistência ou frequência das fezes em lactentes ou crianças pequenas
HUE046924T2 (hu) Módszerek és készítmények Barth szindróma megelõzésében vagy kezelésében történõ alkalmazásra
PL2968478T3 (pl) Kompozycje i sposoby do leczenia karboksyhemoglobinemii
PL2961822T3 (pl) Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie
PL2989192T3 (pl) Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie
IL246587A0 (en) Preparations for use in the treatment of allergic conditions
EP2994147A4 (en) Compositions and methods for the treatment of tinnitus
PL2862576T3 (pl) Drobnoustroje i zawierające je kompozycje do stosowania do leczenia lub profilaktyki zapalenia sutka
GB201421860D0 (en) Children's play kitchen
PL3041459T3 (pl) Kompozycje przydatne w zapobieganiu lub leczeniu raka skóry
ZA201703638B (en) Nutritional compositions comprising sn-1(3) monoacylglycerols for use in the treatment of growth delay in infants or children
EP2968127A4 (en) LOW GLYCEROL PREPARATIONS FOR HIV TREATMENT AND PREVENTION
TH1601002624A (th) องค์ประกอบสำหรับใช้ในการป้องกันหรือรักษาการติดเชื้อ urt ในทารกหรือเด็ก เล็กที่มีความเสี่ยง
TH1601002626A (th) องค์ประกอบสำหรับใช้ในการป้องกันหรือการรักษาโรคลำไส้อักเสบชนิดเนื้อตาย ในทารกและเด็กเล็ก
AU2013901658A0 (en) Compositions and methods for the treatment of tinnitus